May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Evaluation of Human Deleted in Polyposis 1–Like 1 as a Candidate Glaucoma Gene
Author Affiliations & Notes
  • N. Fuse
    Ophthalmology & Visual Sciences, Tohoku University Grad Sch of Med, Sendai, Japan
  • H. Sato
    Ophthalmology & Visual Sciences, Tohoku University Grad Sch of Med, Sendai, Japan
  • M. Seimiya
    Ophthalmology & Visual Sciences, Tohoku University Grad Sch of Med, Sendai, Japan
  • T. Nakazawa
    Ophthalmology & Visual Sciences, Tohoku University Grad Sch of Med, Sendai, Japan
  • M. Tamai
    Ophthalmology & Visual Sciences, Tohoku University Grad Sch of Med, Sendai, Japan
  • Footnotes
    Commercial Relationships  N. Fuse, None; H. Sato, None; M. Seimiya, None; T. Nakazawa, None; M. Tamai, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4410. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Fuse, H. Sato, M. Seimiya, T. Nakazawa, M. Tamai; Evaluation of Human Deleted in Polyposis 1–Like 1 as a Candidate Glaucoma Gene . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4410.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Deleted in polyposis 1–like 1 (Dp1l1) is a recently identified gene that is expressed abundantly in the mouse ganglion cell layer (ARVO2003;2264). The gene consists of 5 exons and encodes 201 amino acid protein. The Dp1l1 gene was mapped to mouse chromosome 10, and the human homologue is located on chromosome 19. Linkage analysis using sibpairs suggested that the region on chromosome 19 shows high lod scores. The purpose of this study was to evaluate human Dp1l1 (hDp1l1) as a candidate gene for primary open–angle glaucoma (POAG) and normal tension glaucoma (NTG). Methods: Eighty–five unrelated Japanese patients with POAG, 65 unrelated patients with NTG, and 80 normal subjects were studied. An informed consent was obtained from all patients. Genomic DNA was extracted from leukocytes of the peripheral blood, and 5 the exons of the hDp1l1 gene were amplified by polymerase chain reaction (PCR) and directly sequenced. Results: We identified a new C to A polymorphism (GCC>GAC) in exon 4 that causes an Ala150Asp amino acid substitution. The frequency of the hDp1l1 CC, CA, and AA genotypes were 66/18/1 in POAG, 52/13/0 in NTG, and 69/11/0 in normal subjects (22.4% vs. 13.8%, 20.0% vs. 13.8%; P = 0.16 and P = 0.37, respectively, for the dominant effect of the hDp1l1 A allele). There was no statistically significant increase in the prevalence of POAG/NTG associated with this base change. Conclusions: Our findings indicate that there is no association with this sequence variant and POAG/NTG. However, our findings do not completely exclude the possibility of an association of POAG/NTG prevalence and hDp1l1 mutation in the Japanese population. We are currently investigating DNA from additional glaucoma subjects and normal control subjects.

Keywords: genetics • gene screening • ganglion cells 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×